- About About
Medical Patient Resources Cannabis Care Certification Patient's Guide to Medical Cannabis Patient's Guide to CBD Talking to your doctor Become a Legal Medical Marijuana Patient The Medical Cannabis Patient’s Guide for U.S. Travel Guide to Using Medical Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Arthritis and Medical Cannabis Cancer and Medical Cannabis Chronic Pain and Medical Cannabis Gastrointestinal Disorders and Medical Cannabis HIV/AIDS and Medical Cannabis Movement Disorders and Medical Cannabis Multiple Sclerosis and Medical Cannabis Aging and Medical Cannabis Veterans and Medical Cannabis Medical Marijuana Conditions in Your Area Growing Cannabis Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources Medical Cannabis Continuing Medical Education (CME) Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Policy Positions Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Data Quality Act Briefs Fact Sheet on ASA's Data Quality Act Petition to HHS ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2021 State of the States Cannabis and Cannabis Resin- Critical Review Preparation Document Medical Cannabis in America
- News News
- Join Join
The California Court of Appeal for the Second Appellate District issued an opinion yesterday in Pack v. City of Long Beach, a case involving a medical marijuana dispensary ordinance adopted last year by the Long Beach City Council. The court did not invalidate the ordinance in its entirety, but instead found that federal law preempted certain provisions of the city’s permitting scheme. In particular, the court found that the provisions of the ordinance granting permits to dispensaries through a lottery system at a significant, recurring fee, are preempted by federal law.
Notably, the court made a distinction between a permitting or licensing scheme and an ordinance that would merely protect such facilities against local civil or criminal prosecution. This leaves open the possibility that Long Beach could comply with the court’s decision simply by making semantic changes to its ordinance, requiring “registration” rather than “permits” or “licenses.”
The Long Beach decision expressly disagrees with two published decisions on federal preemption by the Court of Appeal for the Fourth Appellate District, one in County of San Diego v. San Diego NORML and another in Qualified Patients Association v. City of Anaheim. Because of this appellate conflict, the Long Beach decision is not binding on trial courts outside of the Second Appellate District. Sadly, this ruling creates more uncertainty about localized medical marijuana distribution, instead of resolving it.
Americans for Safe Access (ASA) argued against federal preemption in the Long Beach case by filing an amicus ‘friend of the court’ brief in June with the American Civil Liberties Union (ACLU) and the Drug Policy Alliance (DPA). Unfortunately, the court disregarded those arguments and chose to throw a wrench into the implementation of California’s medical marijuana law.
ASA will, in all certainty, file a request for depublication of the Long Beach decision, which is not yet final. There is a possibility that the California Supreme Court will grant review of the decision or depublish it, especially since it is our belief that the court applied an incorrect preemption analysis.